Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study

PURPOSE: This phase II study was conducted to determine the response rate associated with use of irinotecan and temozolomide for children with relapsed/refractory neuroblastoma. PATIENTS AND METHODS: Patients with relapsed/refractory neuroblastoma measurable by cross-sectional imaging (stratum 1) or...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bagatell, Rochelle, London, Wendy B., Wagner, Lars M., Voss, Stephan D., Stewart, Clinton F., Maris, John M., Kretschmar, Cynthia, Cohn, Susan L.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058276/
https://ncbi.nlm.nih.gov/pubmed/21115869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.7107
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares